Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype

Author:

Lupo Barbara12ORCID,Sassi Francesco2,Pinnelli Marika12ORCID,Galimi Francesco12ORCID,Zanella Eugenia R.2ORCID,Vurchio Valentina12ORCID,Migliardi Giorgia12ORCID,Gagliardi Paolo Armando12ORCID,Puliafito Alberto12ORCID,Manganaro Daria3,Luraghi Paolo2,Kragh Michael4,Pedersen Mikkel W.4ORCID,Horak Ivan D.4,Boccaccio Carla12ORCID,Medico Enzo12ORCID,Primo Luca12ORCID,Nichol Daniel5,Spiteri Inmaculada5ORCID,Heide Timon5ORCID,Vatsiou Alexandra5,Graham Trevor A.6ORCID,Élez Elena7,Argiles Guillem7,Nuciforo Paolo7ORCID,Sottoriva Andrea5ORCID,Dienstmann Rodrigo7,Pasini Diego38ORCID,Grassi Elena2ORCID,Isella Claudio12,Bertotti Andrea12ORCID,Trusolino Livio12ORCID

Affiliation:

1. Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.

2. Candiolo Cancer Institute—FPO IRCCS, 10060 Candiolo, Torino, Italy.

3. European Institute of Oncology, 20139 Milano, Italy.

4. Symphogen A/S, 2750 Ballerup, Denmark.

5. The Institute of Cancer Research, London SW7 3RP, UK.

6. Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

7. Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.

8. Department of Health Sciences, University of Milano, 20142 Milano, Italy.

Abstract

Drug tolerance in EGFR-inhibited mCRC involves secretory pseudodifferentiation and rewiring of oncogenic dependencies.

Funder

European Research Council

Associazione Italiana per la Ricerca sul Cancro

Fondazione Piemontese per la Ricerca sul Cancro-ONLUS

H2020 INFRAIA

Eranet Transcan

European Union H2020 Programme

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3